|
Volumn 165, Issue 10, 2000, Pages 5552-5557
|
Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
4 AMINO 2 ETHOXYMETHYL ALPHA,ALPHA DIMETHYL 1H IMIDAZO [4,5 C]QUINOLINE;
CD40 ANTIGEN;
IMIDAZOQUINOLINE DERIVATIVE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
IMMUNOMODULATING AGENT;
INTERLEUKIN 6;
RESIQUIMOD;
STRESS ACTIVATED PROTEIN KINASE;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
B LYMPHOCYTE ACTIVATION;
B LYMPHOCYTE DIFFERENTIATION;
CONTROLLED STUDY;
DRUG EFFICACY;
ENZYME ACTIVATION;
IMMUNE RESPONSE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
REGULATORY MECHANISM;
SIGNAL TRANSDUCTION;
|
EID: 0034669965
PISSN: 00221767
EISSN: None
Source Type: Journal
DOI: 10.4049/jimmunol.165.10.5552 Document Type: Article |
Times cited : (67)
|
References (58)
|